India’s Zydus, Lupin sign deal to co‑market semaglutide injections

March 17 (Reuters) – Indian drugmakers Zydus Lifesciences and Lupin have signed a licensing and supply deal on Tuesday to co‑market semaglutide injections in the country ahead of the ingredient’s …